363 related articles for article (PubMed ID: 29385755)
41. Vision 20/20: Magnetic resonance imaging-guided attenuation correction in PET/MRI: Challenges, solutions, and opportunities.
Mehranian A; Arabi H; Zaidi H
Med Phys; 2016 Mar; 43(3):1130-55. PubMed ID: 26936700
[TBL] [Abstract][Full Text] [Related]
42. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
Allen TM; Mumbengegwi DR; Charrois GJ
Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
[TBL] [Abstract][Full Text] [Related]
43. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
44. Recent advances in hybrid molecular imaging systems.
Lee JS; Kim JH
Semin Musculoskelet Radiol; 2014 Apr; 18(2):103-22. PubMed ID: 24715444
[TBL] [Abstract][Full Text] [Related]
45. Liposomal antibiotics for the treatment of infectious diseases.
Alhariri M; Azghani A; Omri A
Expert Opin Drug Deliv; 2013 Nov; 10(11):1515-32. PubMed ID: 23886421
[TBL] [Abstract][Full Text] [Related]
46. Liposome-based delivery system for vaccine candidates: constructing an effective formulation.
Giddam AK; Zaman M; Skwarczynski M; Toth I
Nanomedicine (Lond); 2012 Dec; 7(12):1877-93. PubMed ID: 23249332
[TBL] [Abstract][Full Text] [Related]
47. Molecular Imaging of Abdominal Aortic Aneurysms.
Brangsch J; Reimann C; Collettini F; Buchert R; Botnar RM; Makowski MR
Trends Mol Med; 2017 Feb; 23(2):150-164. PubMed ID: 28110838
[TBL] [Abstract][Full Text] [Related]
48. Molecular imaging with SPECT as a tool for drug development.
Gomes CM; Abrunhosa AJ; Ramos P; Pauwels EK
Adv Drug Deliv Rev; 2011 Jun; 63(7):547-54. PubMed ID: 20933557
[TBL] [Abstract][Full Text] [Related]
49. SPECT/CT imaging of temperature-sensitive liposomes for MR-image guided drug delivery with high intensity focused ultrasound.
de Smet M; Langereis S; van den Bosch S; Bitter K; Hijnen NM; Heijman E; Grüll H
J Control Release; 2013 Jul; 169(1-2):82-90. PubMed ID: 23598044
[TBL] [Abstract][Full Text] [Related]
50. Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain.
Saito R; Krauze MT; Bringas JR; Noble C; McKnight TR; Jackson P; Wendland MF; Mamot C; Drummond DC; Kirpotin DB; Hong K; Berger MS; Park JW; Bankiewicz KS
Exp Neurol; 2005 Dec; 196(2):381-9. PubMed ID: 16197944
[TBL] [Abstract][Full Text] [Related]
51. Improving Cerebral Blood Flow Through Liposomal Delivery of Angiogenic Peptides: Potential of ¹⁸F-FDG PET Imaging in Ischemic Stroke Treatment.
Hwang H; Jeong HS; Oh PS; Na KS; Kwon J; Kim J; Lim S; Sohn MH; Jeong HJ
J Nucl Med; 2015 Jul; 56(7):1106-11. PubMed ID: 25977466
[TBL] [Abstract][Full Text] [Related]
52. Multimodal liposomes for SPECT/MR imaging as a tool for in situ relaxivity measurements.
de Vries A; Kok MB; Sanders HM; Nicolay K; Strijkers GJ; Grüll H
Contrast Media Mol Imaging; 2012; 7(1):68-75. PubMed ID: 22344882
[TBL] [Abstract][Full Text] [Related]
53. Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model.
Kesisoglou F; Zhou SY; Niemiec S; Lee JW; Zimmermann EM; Fleisher D
Pharm Res; 2005 Aug; 22(8):1320-30. PubMed ID: 16078142
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic Applications of Liposomal Based Drug Delivery and Drug Targeting for Immune Linked Inflammatory Maladies: A Contemporary View Point.
Rahman M; Beg S; Verma A; Kazmi I; Patel DK; Anwar F; Al Abbasi FA; Kumar V
Curr Drug Targets; 2017; 18(13):1558-1571. PubMed ID: 28413980
[TBL] [Abstract][Full Text] [Related]
55. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.
Goins B; Bao A; Phillips WT
Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538
[TBL] [Abstract][Full Text] [Related]
56. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine.
Man F; Gawne PJ; T M de Rosales R
Adv Drug Deliv Rev; 2019 Mar; 143():134-160. PubMed ID: 31170428
[TBL] [Abstract][Full Text] [Related]
57. Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes.
Abdul Nasir NA; Agarwal P; Agarwal R; Iezhitsa I; Alyautdin R; Nukolova NN; Chekhonin VP; Mohd Ismail N
Drug Deliv; 2016 Oct; 23(8):2765-2771. PubMed ID: 26289215
[TBL] [Abstract][Full Text] [Related]
58. Fate of linear and branched polyether-lipids in vivo in comparison to their liposomal formulations by 18F-radiolabeling and positron emission tomography.
Reibel AT; Müller SS; Pektor S; Bausbacher N; Miederer M; Frey H; Rösch F
Biomacromolecules; 2015 Mar; 16(3):842-51. PubMed ID: 25647509
[TBL] [Abstract][Full Text] [Related]
59. A temperature-sensitive liposomal 1H CEST and 19F contrast agent for MR image-guided drug delivery.
Langereis S; Keupp J; van Velthoven JL; de Roos IH; Burdinski D; Pikkemaat JA; Grüll H
J Am Chem Soc; 2009 Feb; 131(4):1380-1. PubMed ID: 19173663
[TBL] [Abstract][Full Text] [Related]
60. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.
Mulder WJ; Strijkers GJ; van Tilborg GA; Griffioen AW; Nicolay K
NMR Biomed; 2006 Feb; 19(1):142-64. PubMed ID: 16450332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
